Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.30 |
| ▸ | BRD7 | Q9NPI1 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4156055 | 0.86 | CYP2A6 (0.39) | CYP2A6TDP1CYP1A2ADORA2AADORA1 | |
| SCHEMBL8913546 | 0.84 | — | — | |
| SCHEMBL321122 | 0.83 | TDP1 (0.39) | CYP2A6TDP1CYP1A2ALDH1A1CYP3A4 | |
| SCHEMBL7622283 | 0.80 | CYP2A6 (0.41) | CYP2A6TDP1CYP1A2ALDH1A1HPGD | |
| SCHEMBL79020 | 0.78 | ALDH1A1 (0.35) | CYP2A6TDP1ALDH1A1TSHRHSD17B10 | |
| SCHEMBL239122 | 0.77 | CYP2A6 (0.37) | CYP2A6TDP1CYP1A2ALDH1A1CYP3A4 | |
| SCHEMBL1719526 | 0.77 | GSTP1 (0.44) | CYP1A2ALDH1A1CYP2C9HPGDSMN1; SMN2 | |
| SCHEMBL4216130 | 0.76 | ESR1 (0.38) | TDP1CYP1A2ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL8359885 | 0.76 | MEN1 (0.42) | TDP1CYP1A2ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL11516832 | 0.75 | MAOA (0.47) | TDP1ALDH1A1CYP3A4HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1849778-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE EPOXY COMPOUND, COMPLEX FOR USE IN THE PROCESS, AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE & TECH AGENCY (JP) | 2013-04-24 | — | — | EP | disclosed |
| US-8410295-B2 | Method for production of optically active epoxy compound, and complex used therefor and process for producing the same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-04-02 | — | — | US | disclosed |
| US-8394974-B2 | Process for producing optically active chromene oxide compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-12 | — | — | US | disclosed |
| US-20120178954-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND, AND COMPLEX USED THEREFOR AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-07-12 | — | — | US | disclosed |
| US-8217184-B2 | Process for producing optically active cis-silyl olefin oxide compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| US-8163941-B2 | Reacting an unsaturated compound with oxidier in presence of a oxidation catalyst | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-04-24 | — | — | US | disclosed |
| EP-1873160-B1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE -HYDROXYPHOSPHONIC ACIDS AND DERIVATIVES THEREOF, OPTICALLY ACTIVE ALUMINUM(SALALEN) COMPLEXES AND PROCESS FOR PRODUCTION OF THE COMPLEXES, AND PROCESS FOR PRODUCTION OF SALALEN LIGANDS | JAPAN SCIENCE & TECH AGENCY (JP) | 2011-07-13 | — | — | EP | disclosed |
| US-20100305338-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE CIS-SILYL OLEFIN OXIDE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-02 | — | — | US | disclosed |
| US-20100081808-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-01 | — | — | US | disclosed |
| EP-2133343-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2009-12-16 | — | — | EP | disclosed |
| US-20040230077-A1 | Method of producing optically active sulfimide compound | KYUSHU UNIVERSITY (JP) | 2004-11-18 | — | — | US | disclosed |
| US-20040220413-A1 | Method of producing optically active aziridine compounds and amine compounds | KYUSHU UNIVERSITY (JP) | 2004-11-04 | — | — | US | disclosed |
| US-20040202971-A1 | Silver halide emulsion, method of preparing the same, and silver halide color photographic photosensitive material and image-forming method using the emulsion | FUJI PHOTO FILM CO., LTD. | 2004-10-14 | — | — | US | disclosed |
| EP-1452523-A2 | Method of producing optically active sulfimide compounds | KYUSHU UNIVERSITY (JP) | 2004-09-01 | — | — | EP | disclosed |
| US-6784302-B2 | HIGHER ENANTIOMERIC EXCESS BY USING A SPECIFIED ZIRCONIUM (SALEN) COMPLEX AS CATALYST TO CONDUCT A BAEYER-VILLIGER REACTION OF A CYCLIC KETONE; OXIDATION USING A HYDROGEN PEROXIDE OXIDIZER TO PRODUCE CYCLIC ESTERS | KYUSHU UNIVERSITY (JP) | 2004-08-31 | — | — | US | disclosed |
| EP-1449831-A1 | Method of producing optically active aziridine compounds and amine compounds | Kyushu University (JP) | 2004-08-25 | — | — | EP | disclosed |
| US-6750004-B2 | SENSITIZED WITH GOLD OR INDIUM COMPLEX | FUJI PHOTO FILM CO., LTD. (JP) | 2004-06-15 | — | — | US | disclosed |
| US-20040010152-A1 | Method of producing optically active lactone compound and complex used in the method | KYUSHU UNIVERSITY (JP) | 2004-01-15 | — | — | US | disclosed |
| EP-1352908-A1 | Method of producing optically active lactone compound and complex used in the method | KYUSHU UNIVERSITY (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-20020155394-A1 | Silver halide emulsion, method of preparing the same, and silver halide color photographic photosensitive material and image-forming method using the emulsion | FUJI PHOTO FILM CO., LTD. | 2002-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010152-A1 | Method of producing optically active lactone compound and complex used in the method | CYC1, CYP11B1, CYP17A1 | CYP2A6 598/4885TDP1 4611/4885CYP1A2 159/4885 |
| US-20100081808-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND | OSTC, EEF1D, SQLE | CYP2A6 1204/4885TDP1 4469/4885CYP1A2 1135/4885 |
| US-20100305338-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE CIS-SILYL OLEFIN OXIDE COMPOUND | CYP51A1, MSMO1, SQLE | CYP2A6 106/4885TDP1 4601/4885CYP1A2 47/4885 |
| US-20040230077-A1 | Method of producing optically active sulfimide compound | TST, STS, ARSA | CYP2A6 1033/4885TDP1 4842/4885CYP1A2 646/4885 |
| US-20040220413-A1 | Method of producing optically active aziridine compounds and amine compounds | AOC2, AZI2, SRM | CYP2A6 762/4885TDP1 3968/4885CYP1A2 202/4885 |
| US-20120178954-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND, AND COMPLEX USED THEREFOR AND PROCESS FOR PRODUCING THE SAME | CYP4F11, CYP51A1, COASY | CYP2A6 212/4885TDP1 4140/4885CYP1A2 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.